Otsuka Pharmaceutical Factory, Inc. is the startup company of Otsuka Group companies—founded in 1921 from which the Otsuka Group has grown.
For more than 70 years we have been developing intravenous (IV) solutions as a leading infusion company.
In addition to IV solutions, Otsuka Pharmaceutical Factory, Inc. has been engaging in R&D and marketing products which create new value by meeting unmet medical needs in the field of therapeutic medicine related to clinical nutrition, medical foods, medical devices, surgical aid, and regenerative medicine.
For more than 70 years we have been developing intravenous (IV) solutions as a leading infusion company.
In addition to IV solutions, Otsuka Pharmaceutical Factory, Inc. has been engaging in R&D and marketing products which create new value by meeting unmet medical needs in the field of therapeutic medicine related to clinical nutrition, medical foods, medical devices, surgical aid, and regenerative medicine.
Ticker:
4578
Exchange:
TYO
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Japan
Year Founded:
1921
Main Therapeutic Focus:
Gene/Cell Therapy
Lead Product in Development:
OPF-310: Novel encapsulated neonatal porcine islets for treatment of Type 1 diabetes
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
